Evolus, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 7.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Details
| Name | Evolus, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 353 |
| Founded | 2012 |
| Ipo Date | 2018-02-08 |
| Ceo | David Moatazedi |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US30052C1071 |
| Cusip | 30052C107 |
| Cik | 0001570562 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| David Moatazedi | President, Chief Executive Officer and Director |
| Tatjana Mitchell | Chief Financial Officer |
| Dr. Rui Avelar C.CFP, Dip.SportMed, M.D. | Chief Medical Officer and Head of Research and Development |
| Nareg Sagherian | Head of Global Investor Relations and Corporate Communications |
| Kurt Knab | Senior Vice President of Sales |
| Jessica Novak | Senior Vice President of Human Resources |
| Jeffrey J. Plumer | Corporate Secretary |
Contact
| Address | 520 Newport Center Drive, Suite 1200, Newport Beach, California 92660, United States |
| Phone | 949 284 4555 |
| Website | https://www.evolus.com |